FRIDAY, Feb. 12, 2021 (HealthDay Information) — Giving blood thinners to COVID-19 sufferers quickly after they’re hospitalized may scale back their danger of dying.
That is the conclusion of a brand new examine that analyzed information from the U.S. Division of Veterans Affairs on practically 4,300 sufferers, common age 68, who had been hospitalized with COVID between March 1 and July 31.
Of these, greater than 84% obtained blood thinners inside 24 hours of admission — a step referred to as prophylactic anticoagulation.
Within the 30 days after admission, the general dying price was 14.5%.
The dying price was 14.3% amongst sufferers who obtained the blood thinners and 18.7% amongst those that didn’t.
The profit gave the impression to be better amongst sufferers who weren’t admitted to intensive care inside 24 hours of hospitalization.
Researchers stated they accounted for different doubtlessly vital elements corresponding to sufferers’ age, ethnicity, underlying well being situations, remedy historical past, weight and tobacco use.
Considerably, sufferers who obtained blood thinners did not have the next danger of significant bleeding than those that did not obtain blood thinners, in keeping with the staff led by Christopher Rentsch, an assistant professor at London College of Hygiene and Tropical Drugs in England. The findings had been printed Feb. 11 within the BMJ.
Medical trials are being performed to find out if prophylactic anticoagulation could possibly be an efficient remedy for COVID-19.
Till outcomes from these trials can be found, this examine’s findings “present robust actual world proof to assist pointers recommending the usage of prophylactic anticoagulation as preliminary remedy for sufferers with COVID-19 on hospital admission,” Rentsch and his colleagues stated in a journal information launch.
The U.S. Facilities for Illness Management and Prevention has extra on COVID-19.
SOURCE: BMJ, information launch, Feb. 11, 2021